Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Research output
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
Phase 1b Open-label, Dose-Identification Study of XPro1595 in Patients with Mild to Moderate Alzheimer's Disease with Elevated high sensitivity C-reactive protein in Blood.
O'Brien, Terence
(Primary Chief Investigator (PCI))
Burn, Katherine
(Project Manager)
Woodward, Michael Clifford
(Chief Investigator (CI))
Lai, Rosalyn
(Chief Investigator (CI))
Clarnette, Roger
(Chief Investigator (CI))
Brodtmann, Amy
(Chief Investigator (CI))
Nestor, Peter J
(Chief Investigator (CI))
Department of Neuroscience
Eastern Health Clinical School
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
25/09/19
→
31/08/22
View all
View less
Keywords
Neuroscience
Alzheimer's disease
Clinical trial